News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CytomX Therapeutics Appoints Sean McCarthy as Chief Business Officer



1/5/2011 8:45:26 AM

(BUSINESS WIRE)--CytomX Therapeutics, a biotechnology company focused on the development of proteolytically-activated antibodies, today announced the appointment of Sean McCarthy, D.Phil., as chief business officer. McCarthy has more than 15 years of experience in the biotech industry, including business development, venture capital and program management.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES